Niagen Bioscience (NAGE) Inventory Average (2011 - 2026)

Niagen Bioscience (NAGE) has reported Inventory Average for 14 consecutive years, with $22.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory Average rose 118.09% year-over-year to $22.2 million; the TTM figure through Mar 2026 stood at $22.2 million (up 118.09% YoY), while the FY2025 annual figure was $14.8 million, up 24.87% from the prior year.
• Inventory Average improved to $22.2 million in Q1 2026 per NAGE's latest filing, from $19.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $22.2 million in Q1 2026 and bottomed at $9.9 million in Q4 2024.
• Historically, Inventory Average has averaged $14.1 million across 5 years, with a median of $13.5 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory Average slipped 27.3% — and 2026, when it surged 118.09%.
• Niagen Bioscience's Inventory Average stood at $15.2 million in 2022, then slipped by 10.44% to $13.6 million in 2023, then retreated by 27.3% to $9.9 million in 2024, then soared by 98.7% to $19.6 million in 2025, then rose by 13.32% to $22.2 million in 2026.
• Business Quant data shows NAGE's Inventory Average at $22.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.6 million in Q3 2025.